Joanna L Elson Selected Research

Mitochondrial DNA (mtDNA)

1/2022	Mitochondrial DNA variation in Parkinson's disease: Analysis of "out-of-place" population variants as a risk factor.
1/2022	Mitochondrial DNA population variation is not associated with Alzheimer's in the Japanese population: A consistent finding across global populations.
8/2021	Investigation of the correlation between mildly deleterious mtDNA Variations and the clinical progression of multiple sclerosis.
1/2021	Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease.
12/2020	Mitochondrial DNA mutations induce mitochondrial biogenesis and increase the tumorigenic potential of Hodgkin and Reed-Sternberg cells.
1/2020	Evolutionary dissection of mtDNA hg H: a susceptibility factor for hypertrophic cardiomyopathy.
10/2019	The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.
1/2019	MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants.
1/2019	Implementing a new variant load model to investigate the role of mtDNA in oxidative stress and inflammation in a bi-ethnic cohort: the SABPA study.
3/2018	The aetiology of cardiovascular disease: a role for mitochondrial DNA?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna L Elson Research Topics

Disease

16	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 11/2002
14	Parkinson Disease (Parkinson's Disease) 02/2023 - 01/2008
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 11/2005
4	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2019 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2017
2	Parkinsonian Disorders (Parkinsonism) 12/2013 - 01/2008
2	Muscular Diseases (Myopathy) 09/2010 - 11/2002
1	Multiple Sclerosis 08/2021
1	Disease Progression 08/2021
1	Neoplasms (Cancer) 12/2020
1	Hodgkin Disease (Hodgkin's Disease) 12/2020
1	Poisoning 01/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Atherosclerosis 01/2018
1	Obesity 01/2018
1	Cognitive Dysfunction 01/2018
1	Hypertension (High Blood Pressure) 01/2017
1	Fatigue 01/2017
1	Amyloid Plaque 07/2012
1	Dementia (Dementias) 03/2012
1	Cardiomyopathies (Cardiomyopathy) 09/2010
1	Brain Diseases (Brain Disorder) 09/2010
1	Hearing Loss (Hearing Impairment) 09/2010
1	Neuromyelitis Optica (Devic's Disease) 04/2008
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2007
1	Infections 12/2005
1	Sepsis (Septicemia) 12/2005
1	Cytochrome-c Oxidase Deficiency 11/2002

Drug/Important Bio-Agent (IBA)

28	Mitochondrial DNA (mtDNA)IBA 01/2022 - 11/2002
3	Chelating AgentsIBA 02/2023 - 01/2020
3	Transfer RNA (tRNA)IBA 01/2021 - 09/2010
3	Cholinergic Agents (Cholinergics)IBA 01/2018 - 01/2015
2	IronIBA 02/2023 - 01/2020
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2021 - 03/2012
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2019
2	lactacystinIBA 01/2018 - 01/2016
1	CoumarinsIBA 02/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	MetalsIBA 01/2020
1	UbiquitinIBA 01/2020
1	NeuropeptidesIBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	GalaninIBA 01/2018
1	Dopamine Agents (Dopaminergic Agents)IBA 09/2015
1	Amyloid beta-PeptidesIBA 07/2012
1	Peptides (Polypeptides)IBA 07/2012
1	SynucleinsIBA 03/2012
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2002

Therapy/Procedure

2	Deep Brain Stimulation 02/2015 - 01/2015
2	Therapeutics 12/2013 - 09/2010
1	Exercise Therapy (Therapy, Exercise) 01/2011